Csenge Advisory Group Regeneron Pharmaceuticals, Inc. Transaction History

Csenge Advisory Group

$1.77 Billion
Q1 2024

A detailed history of Csenge Advisory Group transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Csenge Advisory Group holds 449 shares of REGN stock, worth $471,912. This represents 0.02% of its overall portfolio holdings.

Number of Shares

449

Previous 400 12.25%

Holding current value

$471,912

Previous $351,000 23.08%

% of portfolio

0.02%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$902.69 - $993.35 $44,231 - $48,674	49 Added 12.25%	449 $432,000
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $82,944 - $94,341	107 Added 36.52%	400 $351,000
Q3 2023 Nov 01, 2023	BUY	$692.45 - $844.37 $202,887 - $247,400	293 New	293 $241,000
Q1 2023 May 01, 2023	SELL	$680.49 - $826.97 $9,526 - $11,577	-14 Reduced 5.04%	264 $216,000
Q4 2022 Feb 10, 2023	BUY	$705.89 - $766.39 $196,237 - $213,056	278 New	278 $200,000

Q2 2022 Jul 27, 2022	SELL	$548.35 - $738.84 $165,601 - $223,129	-302 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$595.12 - $698.43 $179,726 - $210,925	302 New	302 $211,000
Q1 2021 Apr 28, 2021	SELL	$446.73 - $548.2 $186,286 - $228,599	-417 Closed	0 $0
Q4 2020 Jan 26, 2021	SELL	$478.3 - $607.98 $370,204 - $470,576	-774 Reduced 64.99%	417 $201,000
Q3 2020 Nov 09, 2020	BUY	$544.75 - $658.21 $1,634 - $1,974	3 Added 0.25%	1,191 $693,000
Q2 2020 Jul 17, 2020	BUY	$493.32 - $643.92 $269,352 - $351,580	546 Added 85.05%	1,188 $741,000
Q1 2020 Apr 21, 2020	BUY	$336.18 - $494.43 $215,827 - $317,424	642 New	642 $313,000
Q4 2018 Feb 07, 2019	SELL	$335.82 - $403.04 $1,007 - $1,209	-3 Closed	0 $0
Q3 2018 Nov 19, 2018	BUY	$351.14 - $408.51 $1,053 - $1,225	3 New	3 $1,000

Others Institutions Holding REGN

# of Institutions

1,424

Shares Held

82.1M

Call Options Held

835K

Put Options Held

1.46M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $113B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Csenge Advisory Group with notifications on news.

Account

Csenge Advisory Group Regeneron Pharmaceuticals, Inc. Transaction History